Glenmark Life Sciences IPO vs KIMS IPO

Comparision between Glenmark Life Sciences IPO and KIMS IPO.

IPO Details

Glenmark Life Sciences IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while KIMS IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

	Glenmark Life Sciences IPO	KIMS IPO
Logo
Issue Category	Mainline	Mainline
Issue Type	IPO	IPO
Process Type	Book Built Issue	Book Built Issue
Listing At	BSE, NSE	BSE, NSE
Lead Managers	Bofa Securities India Limited Bob Capital Markets Limited Dam Capital Advisors Ltd (Formerly Idfc Securities Ltd) Goldman Sachs (India) Securities Private Limited Kotak Mahindra Capital Company Limited SBI Capital Markets Limited	Axis Capital Limited Credit Suisse Securities (India) Private Limited Iifl Securities Ltd Kotak Mahindra Capital Company Limited
Registrar	Kfin Technologies Limited	Link Intime India Private Ltd
Market Maker
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Glenmark Life Sciences IPO is up to ₹1,513.60 Cr whereas the issue size of the KIMS IPO is up to ₹2,143.74 Cr. The final issue price of Glenmark Life Sciences IPO is ₹720.00 per share and of KIMS IPO is ₹825.00 per share.

	Glenmark Life Sciences IPO	KIMS IPO
Face Value	₹2 per share	₹10 per share
Issue Price (Lower)	₹695.00 per share	₹815.00 per share
Issue Price (Upper)	₹720.00 per share	₹825.00 per share
Issue Price (Final)	₹720.00 per share	₹825.00 per share
Discount (Retail)
Discount (Employee)		₹40.00 per share
Market Lot Size	20 shares	18 shares
Fresh Issue Size		24,24,242 shares
Fresh Issue Size (Amount)	up to ₹1,060.00 Cr	up to ₹200.00 Cr
OFS Issue Size	63,00,000 shares	2,35,60,538 shares
OFS Issue Size (Amount)	up to ₹453.60 Cr	up to ₹1,943.74 Cr
Issue Size Total
Issue Size Total (Amount)	up to ₹1,513.60 Cr	up to ₹2,143.74 Cr

IPO Timetable

Glenmark Life Sciences IPO opens on Jul 27, 2021, while KIMS IPO opens on Jun 16, 2021. The closing date of Glenmark Life Sciences IPO and KIMS IPO is Jul 29, 2021, and Jun 18, 2021, respectively.

	Glenmark Life Sciences IPO	KIMS IPO
Anchor Bid Date
Issue Open	Jul 27, 2021	Jun 16, 2021
Issue Close	Jul 29, 2021	Jun 18, 2021
Basis Of Allotment (Tentative)	Aug 03, 2021	Jun 23, 2021
Initiation of Refunds (Tentative)	Aug 04, 2021	Jun 24, 2021
Credit of Share (Tentative)	Aug 05, 2021	Jun 25, 2021
Listing date (Tentative)	Aug 06, 2021	Jun 28, 2021
Anchor Lockin End date 1	Sep 02, 2021	Jul 23, 2021
Anchor Lockin End date 2	Nov 01, 2021	Sep 21, 2021

Financials

Glenmark Life Sciences IPO P/E ratio is , as compared to KIMS IPO P/E ratio of .

Glenmark Life Sciences IPO

KIMS IPO

Financial

Summary of financial Information (Restated Consolidated)
Particulars	For the year/period ended (₹ in million)
	31-Mar-21	31-Mar-20	31-Mar-19
Total Assets	19,970.75	17,256.04	14,753.95
Total Revenue	18,859.76	15,493.03	8,868.65
Profit After Tax	3,515.81	3,130.98	1,955.92

Summary of financial Information (Restated Consolidated)
Particulars	For the year/period ended (₹ in millions)
	31-Mar-21	31-Mar-20	31-Mar-19
Total Assets	14,361.54	11,958.90	11,197.13
Total Revenue	13,401.02	11,287.28	9,238.69
Profit After Tax	2,054.79	1,150.72	(488.07)

Promoter Shareholding (Pre-Issue)

100%

46.81%

Promoter Shareholding (Post-Issue)

82.84%

38.84%

P/E Ratio

Market Cap

ROE

ROCE

Debt/Equity

EPS

RoNW

Shares Offered

In the Glenmark Life Sciences IPO retail investors (RII) are offered 75,43,130 shares while in KIMS IPO retail investors are offered 75,43,130 shares. Qualified institutional buyers (QIB) are offered 42,42,379 shares in Glenmark Life Sciences IPO and 77,22,708 shares in KIMS IPO.

	Glenmark Life Sciences IPO	KIMS IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB	42,42,379 shares	77,22,708 shares
NII	32,32,770 shares	38,61,353 shares
RII	75,43,130 shares	25,74,235 shares
Employee	0 shares	2,54,777 shares
Others
Total	1,50,18,279 shares	1,44,13,073 shares

Bids Received (Subscription)

Glenmark Life Sciences IPO subscribed 44.17x in total, whereas KIMS IPO subscribed 3.86x.

	Glenmark Life Sciences IPO	KIMS IPO
QIB (times)	36.97x	5.26x
NII (times)	122.54x	1.89x
Big NII (times)
Small NII (times)
RII (times)	14.63x	2.90x
Employee (times)		1.06x
Other (times)
Total (times)	44.17x	3.86x

Compare with others

Glenmark Life Sciences IPO	KIMS IPO
Nuvoco IPO	Glenmark Life Sciences IPO
Rolex Rings IPO	Clean Science IPO
Paytm IPO	G R Infraprojects IPO
Tatva Chintan Pharma IPO	India Pesticides IPO
Zomato IPO	Ruchi Soya FPO
Clean Science IPO	Dodla Dairy IPO
G R Infraprojects IPO	Sona Comstar IPO
India Pesticides IPO	POWERGRID InvIT IPO April 2021
Ruchi Soya FPO	Shyam Metalics IPO
KIMS IPO	Lodha Developers IPO

Comments

Add a public comment...